We think there’s room in the life science industry for a new kind of company that relies on a mix of deep lab expertise and data-driven computing to get new treatments to market much faster and more efficiently than older approaches. We call that combination TechBio.

From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share
Relevant content




